164 related articles for article (PubMed ID: 19490272)
1. Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome.
Jons C; Moss AJ; Lopes CM; McNitt S; Zareba W; Goldenberg I; Qi M; Wilde AA; Shimizu W; Kanters JK; Towbin JA; Ackerman MJ; Robinson JL
J Cardiovasc Electrophysiol; 2009 Aug; 20(8):859-65. PubMed ID: 19490272
[TBL] [Abstract][Full Text] [Related]
2. Low incidence of sudden cardiac death in a Swedish Y111C type 1 long-QT syndrome population.
Winbo A; Diamant UB; Stattin EL; Jensen SM; Rydberg A
Circ Cardiovasc Genet; 2009 Dec; 2(6):558-64. PubMed ID: 20031635
[TBL] [Abstract][Full Text] [Related]
3. Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: multicenter study in Japan.
Shimizu W; Horie M; Ohno S; Takenaka K; Yamaguchi M; Shimizu M; Washizuka T; Aizawa Y; Nakamura K; Ohe T; Aiba T; Miyamoto Y; Yoshimasa Y; Towbin JA; Priori SG; Kamakura S
J Am Coll Cardiol; 2004 Jul; 44(1):117-25. PubMed ID: 15234419
[TBL] [Abstract][Full Text] [Related]
4. Biophysical characterization of KCNQ1 P320 mutations linked to long QT syndrome 1.
Thomas D; Khalil M; Alter M; Schweizer PA; Karle CA; Wimmer AB; Licka M; Katus HA; Koenen M; Ulmer HE; Zehelein J
J Mol Cell Cardiol; 2010 Jan; 48(1):230-7. PubMed ID: 19540844
[TBL] [Abstract][Full Text] [Related]
5. In silico cardiac risk assessment in patients with long QT syndrome: type 1: clinical predictability of cardiac models.
Hoefen R; Reumann M; Goldenberg I; Moss AJ; O-Uchi J; Gu Y; McNitt S; Zareba W; Jons C; Kanters JK; Platonov PG; Shimizu W; Wilde AA; Rice JJ; Lopes CM
J Am Coll Cardiol; 2012 Nov; 60(21):2182-91. PubMed ID: 23153844
[TBL] [Abstract][Full Text] [Related]
6. Dominant-negative I(Ks) suppression by KCNQ1-deltaF339 potassium channels linked to Romano-Ward syndrome.
Thomas D; Wimmer AB; Karle CA; Licka M; Alter M; Khalil M; Ulmer HE; Kathöfer S; Kiehn J; Katus HA; Schoels W; Koenen M; Zehelein J
Cardiovasc Res; 2005 Aug; 67(3):487-97. PubMed ID: 15950200
[TBL] [Abstract][Full Text] [Related]
7. The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification.
Crotti L; Spazzolini C; Schwartz PJ; Shimizu W; Denjoy I; Schulze-Bahr E; Zaklyazminskaya EV; Swan H; Ackerman MJ; Moss AJ; Wilde AA; Horie M; Brink PA; Insolia R; De Ferrari GM; Crimi G
Circulation; 2007 Nov; 116(21):2366-75. PubMed ID: 17984373
[TBL] [Abstract][Full Text] [Related]
8. Does pregnancy increase cardiac risk for LQT1 patients with the KCNQ1-A341V mutation?
Heradien MJ; Goosen A; Crotti L; Durrheim G; Corfield V; Brink PA; Schwartz PJ
J Am Coll Cardiol; 2006 Oct; 48(7):1410-5. PubMed ID: 17010804
[TBL] [Abstract][Full Text] [Related]
9. Stop-codon and C-terminal nonsense mutations are associated with a lower risk of cardiac events in patients with long QT syndrome type 1.
Ruwald MH; Xu Parks X; Moss AJ; Zareba W; Baman J; McNitt S; Kanters JK; Shimizu W; Wilde AA; Jons C; Lopes CM
Heart Rhythm; 2016 Jan; 13(1):122-31. PubMed ID: 26318259
[TBL] [Abstract][Full Text] [Related]
10. Long QT syndrome in neonates: conduction disorders associated with HERG mutations and sinus bradycardia with KCNQ1 mutations.
Lupoglazoff JM; Denjoy I; Villain E; Fressart V; Simon F; Bozio A; Berthet M; Benammar N; Hainque B; Guicheney P
J Am Coll Cardiol; 2004 Mar; 43(5):826-30. PubMed ID: 14998624
[TBL] [Abstract][Full Text] [Related]
11. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene.
Moss AJ; Shimizu W; Wilde AA; Towbin JA; Zareba W; Robinson JL; Qi M; Vincent GM; Ackerman MJ; Kaufman ES; Hofman N; Seth R; Kamakura S; Miyamoto Y; Goldenberg I; Andrews ML; McNitt S
Circulation; 2007 May; 115(19):2481-9. PubMed ID: 17470695
[TBL] [Abstract][Full Text] [Related]
12. Mutation location effect on severity of phenotype during exercise testing in type 1 long-QT syndrome: impact of transmembrane and C-loop location.
Laksman ZW; Hamilton RM; Chockalingam P; Ballantyne E; Stephenson EA; Gross GJ; Gula LJ; Klein GJ; Wilde AA; Krahn AD
J Cardiovasc Electrophysiol; 2013 Sep; 24(9):1015-20. PubMed ID: 23691991
[TBL] [Abstract][Full Text] [Related]
13. Long QT syndrome in adults.
Sauer AJ; Moss AJ; McNitt S; Peterson DR; Zareba W; Robinson JL; Qi M; Goldenberg I; Hobbs JB; Ackerman MJ; Benhorin J; Hall WJ; Kaufman ES; Locati EH; Napolitano C; Priori SG; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
J Am Coll Cardiol; 2007 Jan; 49(3):329-37. PubMed ID: 17239714
[TBL] [Abstract][Full Text] [Related]
14. A double-point mutation in the selectivity filter site of the KCNQ1 potassium channel results in a severe phenotype, LQT1, of long QT syndrome.
Ikrar T; Hanawa H; Watanabe H; Okada S; Aizawa Y; Ramadan MM; Komura S; Yamashita F; Chinushi M; Aizawa Y
J Cardiovasc Electrophysiol; 2008 May; 19(5):541-9. PubMed ID: 18266681
[TBL] [Abstract][Full Text] [Related]
15. The G314S KCNQ1 mutation exerts a dominant-negative effect on expression of KCNQ1 channels in oocytes.
Li W; Du R; Wang QF; Tian L; Yang JG; Song ZF
Biochem Biophys Res Commun; 2009 May; 383(2):206-9. PubMed ID: 19348785
[TBL] [Abstract][Full Text] [Related]
16. The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome.
Schwartz PJ; Spazzolini C; Crotti L; Bathen J; Amlie JP; Timothy K; Shkolnikova M; Berul CI; Bitner-Glindzicz M; Toivonen L; Horie M; Schulze-Bahr E; Denjoy I
Circulation; 2006 Feb; 113(6):783-90. PubMed ID: 16461811
[TBL] [Abstract][Full Text] [Related]
17. The N-terminal juxtamembranous domain of KCNQ1 is critical for channel surface expression: implications in the Romano-Ward LQT1 syndrome.
Dahimène S; Alcoléa S; Naud P; Jourdon P; Escande D; Brasseur R; Thomas A; Baró I; Mérot J
Circ Res; 2006 Nov; 99(10):1076-83. PubMed ID: 17053194
[TBL] [Abstract][Full Text] [Related]
18. Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome.
Schwartz PJ; Vanoli E; Crotti L; Spazzolini C; Ferrandi C; Goosen A; Hedley P; Heradien M; Bacchini S; Turco A; La Rovere MT; Bartoli A; George AL; Brink PA
J Am Coll Cardiol; 2008 Mar; 51(9):920-9. PubMed ID: 18308161
[TBL] [Abstract][Full Text] [Related]
19. Impaired ion channel function related to a common KCNQ1 mutation - implications for risk stratification in long QT syndrome 1.
Aidery P; Kisselbach J; Schweizer PA; Becker R; Katus HA; Thomas D
Gene; 2012 Dec; 511(1):26-33. PubMed ID: 23000022
[TBL] [Abstract][Full Text] [Related]
20. Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects.
Koponen M; Marjamaa A; Hiippala A; Happonen JM; Havulinna AS; Salomaa V; Lahtinen AM; Hintsa T; Viitasalo M; Toivonen L; Kontula K; Swan H
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):815-23. PubMed ID: 26063740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
